In a major milestone in equitable cancer treatment, Biocon Biologics partnered with the National Cancer Society of Malaysia (NCSM) to put into action a Patient Assistance Programme (PAP) in order to increase access to affordable, quality...
A major step in the direction of infectious disease research in India, Pune-based National Institute of Virology (NIV), under the Indian Council of Medical Research (ICMR), has found anti-viral drug Favipiravir as a potential candidate against Chandi
In a significant milestone for the evolution of cancer care in India, Glenmark Pharmaceuticals announced the launch of Tevimbra (tislelizumab), an innovative immune-oncology drug of the Central Drugs Standard Control Organization (CDSCO)...
India's pharma and MedTech industries await the change with the launch of the Rs. 5,000-crore Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme.
Danish pharmaceutical leader Novo Nordisk is targeting $1 billion (Rs 8,600 crore) in sales in India with its highly successful weight-loss medication Wegovy (semaglutide) within the next five to seven years. To achieve this goal, ET has learned that
Immuno Cure BioTech, located in Hong Kong Science Park, has formed a partnership with PharmaJet to assess the safety and immunogenicity of ICVAX, Immuno Cure's HIV therapeutic DNA
The Indian Council of Medical Research’s National Institute of Immunohaematology (ICMR-NIIH) has developed the world’s first simple...
The Indian pharma sector is experiencing a remarkable shift, growing from the cost-driven outsourcing model into a bustling center of innovation, research, and international alliances.
Amazon India expanded its healthcare services further with the launch of Amazon Diagnostics, an in-home diagnostic testing service to deliver quick, secure, and easy lab testing to the doorsteps of customers.
In an exclusive interaction with India Pharma Outlook, Dr. Pankaj Gupta, Senior Medical Director at Pfizer India, sheds light on the escalating threat of antimicrobial resistance in India’s ICUs. He discusses evo
, CDSCO.jpg)